Direkt zum Inhalt

Topp, Max S. ; Goekbuget, Nicola ; Zugmaier, Gerhard ; Viardot, Andreas ; Stelljes, Matthias ; Neumann, Svenja ; Horst, Heinz A. ; Reichle, Albrecht ; Marks, Reinhard E ; Brueggemann, Monika ; Ritgen, Matthias ; Klappers, Petra ; Mergen, Noemi ; Goebeler, Marie-Elisabeth ; Einsele, Hermann ; Hoelzer, Dieter ; Bargou, Ralf

Anti-CD19 BiTE Blinatumomab Induces High Complete Remission Rate In Adult Patients with Relapsed B-Precursor ALL: Updated Results of An Ongoing Phase II Trial

Topp, Max S., Goekbuget, Nicola, Zugmaier, Gerhard, Viardot, Andreas, Stelljes, Matthias, Neumann, Svenja, Horst, Heinz A., Reichle, Albrecht, Marks, Reinhard E, Brueggemann, Monika, Ritgen, Matthias, Klappers, Petra, Mergen, Noemi, Goebeler, Marie-Elisabeth, Einsele, Hermann, Hoelzer, Dieter and Bargou, Ralf (2011) Anti-CD19 BiTE Blinatumomab Induces High Complete Remission Rate In Adult Patients with Relapsed B-Precursor ALL: Updated Results of An Ongoing Phase II Trial. Blood 118 (21), p. 252.

Date of publication of this fulltext: 19 Dec 2024 11:04
Article



Involved Institutions


Details

Item typeArticle
Journal or Publication TitleBlood
Publisher:AMER SOC HEMATOLOGY
Place of Publication:WASHINGTON
Volume:118
Number of Issue or Book Chapter:21
Page Range:p. 252
Date2011
InstitutionsMedicine > Lehrstuhl für Innere Medizin III (Hämatologie und Internistische Onkologie)
Identification Number
ValueType
10.1182/blood.V118.21.252.252DOI
Dewey Decimal Classification600 Technology > 610 Medical sciences Medicine
StatusPublished
RefereedYes, this version has been refereed
Created at the University of RegensburgYes
Item ID64372

Export bibliographical data

Owner only: item control page

nach oben